Other
Neoplasm by Morphology
CI-CAN-00000002Explore in graph →
Non-malignant13,325 active trials222 approved drugs2,774 evidence items
- NCIt
- C4741
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000002Explore in graph →
Clinical trials
52,671 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01729663 | Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients | unknown | Phase 2 / Phase 3 | 108 | Laboratorio Pablo Cassara S.R.L.INDUSTRY | 1 | Sep 2, 2015 | clinicaltrials |
| NCT02535507 | Efficacy and Safety of Pyrotinib in Patients With HER2 Mutation Advanced Non-Small Cell Lung Cancer | unknown | Phase 2 | 40 | Tongji UniversityOTHER | 1 | Aug 28, 2015 | clinicaltrials |
| NCT01232374 | Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 144 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Aug 20, 2015 | clinicaltrials |
| NCT02529579 | Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 187 | Changhai HospitalOTHER | 1 | Aug 20, 2015 | clinicaltrials |
| NCT02528526 | Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm(OXY1A) | unknown | Phase 1 / Phase 2 | 69 | University of ZurichOTHER | 1 | Aug 19, 2015 | clinicaltrials |
| NCT01812096 | Study of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma in China(MM) | unknown | Phase 1 / Phase 2 | 20 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Aug 18, 2015 | clinicaltrials |
| NCT01592617 | Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer | unknown | Phase 2 | 45 | Shiga UniversityOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT02426762 | Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery | unknown | Phase 2 | 100 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT01412307 | A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma(LEBEN) | unknown | Phase 1 / Phase 2 | 36 | Istituto Nazionale Tumori IRCCS - Fondazione G. PascaleNETWORK | 1 | Aug 11, 2015 | clinicaltrials |
| NCT02520219 | Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study | unknown | Phase 2 | 60 | Nanjing NingQi Medicine Science and Technology Co., Ltd.INDUSTRY | 1 | Aug 11, 2015 | clinicaltrials |
| NCT02511340 | A Phase II Study to Evaluate the Efficacy and the Safety of Flumatinib in CML-AP or CML-BP Patients | unknown | Phase 2 | 167 | Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 30, 2015 | clinicaltrials |
| NCT00800059 | Total Marrow Irradiation & Autologous Stem Cell Transplantation for Relapsed or Refractory Myeloma(TMI-ASCT) | unknown | Phase 1 / Phase 2 | 27 | Ottawa Hospital Research InstituteOTHER | 1 | Jul 27, 2015 | clinicaltrials |
| NCT02509169 | Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 60 | Shenzhen SiBiono GeneTech Co.,LtdINDUSTRY | 1 | Jul 27, 2015 | clinicaltrials |
| NCT01843647 | Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients | unknown | Phase 2 | 100 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 15, 2015 | clinicaltrials |
| NCT02062515 | Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency | unknown | Phase 2 | 30 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 15, 2015 | clinicaltrials |
| NCT02497053 | Four Versus Six Cycles of Pemetrexed/Platinum for MPM | unknown | Phase 2 | 70 | Ain Shams UniversityOTHER | 1 | Jul 14, 2015 | clinicaltrials |
| NCT02261779 | Phase I/II Trial of ATRA and TCP in Patients With Relapsed or Refractory AML and no Intensive Treatment is Possible(TCP-AML) | unknown | Phase 1 / Phase 2 | 16 | Martin-Luther-Universität Halle-WittenbergOTHER | 1 | Jul 7, 2015 | clinicaltrials |
| NCT02006043 | Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-) | unknown | Phase 2 | 54 | Li ZhangOTHER | 1 | Jul 3, 2015 | clinicaltrials |
| NCT02145715 | Velcade, Thalidomide, Dexamethasone and Panobinostat Treatment and Panobinostat Maintenance in Multiple Myeloma(MUKsix) | unknown | Phase 1 / Phase 2 | 54 | Prof Jamie CavenaghOTHER | 1 | Jun 26, 2015 | clinicaltrials |
| NCT01369368 | Treatment of Acute Leukemia Relapse After Allotransplantation | unknown | Phase 1 / Phase 2 | 20 | University of BergenOTHER | 1 | Jun 24, 2015 | clinicaltrials |
| NCT01757145 | Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood Transplantation | unknown | Phase 2 | 20 | Rabin Medical CenterOTHER | 1 | Jun 19, 2015 | clinicaltrials |
| NCT00524784 | Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD | unknown | Phase 1 / Phase 2 | 12 | Hadassah Medical OrganizationOTHER | 1 | Jun 11, 2015 | clinicaltrials |
| NCT02456207 | A Pharmacokinetic Study Comparing SCT400 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma | unknown | Phase 2 | 80 | Sinocelltech Ltd.INDUSTRY | 1 | May 28, 2015 | clinicaltrials |
| NCT01172925 | Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer(TIDAL) | unknown | Phase 2 | 34 | Hamilton Health Sciences CorporationOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT02452853 | HR Combined With FOLFOX4 for HCC With PVTT | unknown | Phase 2 | 51 | Sun Yat-sen UniversityOTHER | 0 | May 25, 2015 | clinicaltrials |
| NCT01929200 | Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation | unknown | Phase 2 | 120 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | May 22, 2015 | clinicaltrials |
| NCT02027090 | High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable Disease | unknown | Phase 2 | 64 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | May 22, 2015 | clinicaltrials |
| NCT02278978 | BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma | unknown | Phase 2 | 129 | National Taiwan University HospitalOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT02435186 | p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer | unknown | Phase 2 | 100 | Shenzhen SiBiono GeneTech Co.,LtdINDUSTRY | 1 | May 6, 2015 | clinicaltrials |
| NCT02431403 | ESHAP-Imatinib for Refractory/Relapsed Non-Hodgkin's Lymphoma | unknown | Phase 1 / Phase 2 | 94 | Pusan National University HospitalOTHER | 1 | May 5, 2015 | clinicaltrials |
| NCT01960829 | Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study | unknown | Phase 2 | 60 | Peking University Cancer Hospital & InstituteOTHER | 1 | May 1, 2015 | clinicaltrials |
| NCT02430974 | Chemotherapy of NSCLC With or Without Icotinib | unknown | Phase 2 | 50 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 | Apr 30, 2015 | clinicaltrials |
| NCT02427919 | Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML(DeGREE) | unknown | Phase 2 / Phase 3 | 56 | Seoul St. Mary's HospitalOTHER | 1 | Apr 28, 2015 | clinicaltrials |
| NCT02426450 | RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC | unknown | Phase 2 | 28 | Sun Yat-sen UniversityOTHER | 1 | Apr 27, 2015 | clinicaltrials |
| NCT00885508 | A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q(GFM-Chimio-Rev) | unknown | Phase 2 | 85 | Groupe Francophone des MyelodysplasiesOTHER | 1 | Apr 24, 2015 | clinicaltrials |
| NCT02418988 | Trans-catheter Chemo-embolization Combined With rAd-p53 Gene Injection in Treatment of Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 120 | Shenzhen SiBiono GeneTech Co.,LtdINDUSTRY | 1 | Apr 17, 2015 | clinicaltrials |
| NCT02399189 | MT-R Followed by Autologous Stem Cells Transplantation in Newly-diagnosed Primary Central Nervous System Lymphoma | unknown | Phase 2 | 39 | Jun ZhuOTHER | 1 | Apr 13, 2015 | clinicaltrials |
| NCT02409849 | Octreotide LAR as Maintenance Treatment for Patients With NEC | unknown | Phase 2 | 92 | Peking UniversityOTHER | 1 | Apr 7, 2015 | clinicaltrials |
| NCT02407600 | Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy | unknown | Phase 2 | 150 | Ajeet GajraOTHER | 1 | Apr 3, 2015 | clinicaltrials |
| NCT02407366 | Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer | unknown | Phase 2 | 80 | People's Hospital of Guangxi Zhuang Autonomous RegionOTHER | 1 | Apr 2, 2015 | clinicaltrials |
| NCT01549093 | Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 90 | Hunan Province Tumor HospitalOTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT01521689 | Tolerance and Efficacy of Subcutanous Low Doses Rituximab for CLL Consolidation Treatment(LLCRlowdoz) | unknown | Phase 2 | 35 | Institut Paoli-CalmettesOTHER | 1 | Mar 20, 2015 | clinicaltrials |
| NCT02387086 | Gefitinib Combined With Thalidomide to Treat NSCLC | unknown | Phase 2 / Phase 3 | 380 | Bai JunOTHER | 0 | Mar 12, 2015 | clinicaltrials |
| NCT02385955 | Phase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult Patients | unknown | Phase 2 | 39 | Seoul National University HospitalOTHER | 0 | Mar 11, 2015 | clinicaltrials |
| NCT01368757 | Lenalidomide in Patients With Chronic Myelomonocytic Leukemia | unknown | Phase 1 / Phase 2 | 30 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | Mar 9, 2015 | clinicaltrials |
| NCT01298934 | LBH589 (Panobinostat) for the Treatment of Myelofibrosis | unknown | Phase 1 / Phase 2 | 22 | Ronald HoffmanOTHER | 1 | Mar 6, 2015 | clinicaltrials |
| NCT02009605 | Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer | unknown | Phase 2 | 30 | Zhejiang UniversityOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT02376452 | Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Mar 3, 2015 | clinicaltrials |
| NCT01389583 | A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients | unknown | Phase 2 | 25 | National Health Research Institutes, TaiwanOTHER | 1 | Feb 25, 2015 | clinicaltrials |
| NCT00086866 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery | unknown | Phase 2 | 165 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Feb 10, 2015 | clinicaltrials |
Data updated 24 days agoSource updated Sep 2, 2015source: clinicaltrials